Sysmex Astrego is featured on CBS News Global Thought Leader campaign. 

Sysmex Astrego presents poster at the 32nd ECCMID conference.

Sysmex Corporation, Japan, completes outright acquisition of Astrego Diagnostics AB. The new entity Sysmex Astrego AB is formed.


Astrego’s disruptive technology makes it possible to capture individual bacterial cells from complex samples and measure their growth rate in real-time. This enables the fastest possible Antibiotic Susceptibility Test (AST).


Products targeting a wide range of microbiological applications, designed to enable evidence-based prescription of antibiotics and help reduce the spread of antimicrobial resistance (AMR).


Sysmex Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. Our team combines multidisciplinary scientific excellence with seasoned diagnostic industry management.

This website use cookies.
By using the website you consent to this.
Read more here.